On November 3, 2020, the Board of Directors of PDS Biotechnology Corporation appointed Otis W. Brawley, M.D., MACP, FASCO, FACE, as a Class C director and new member of the Board, effective immediately, to serve until the Company's 2021 annual meeting of stockholders or until his earlier resignation or removal. Dr. Brawley was appointed to fill the remaining vacancy on the Board. Dr. Brawley will not serve on any of the Board's committees. Dr. Brawley, age 61, is a board certified Medical Oncologist. Dr. Brawley is the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University, a position he has held since January, 2019. Dr. Brawley is a current member of the National Cancer Institute's (NCI) Board of Scientific Counselors.